Fintan Steele joined SomaLogic in 2011 as executive director for communications. Fintan’s background includes more than 20 years of experience in communicating scientific research, particular the science (and its implications) behind the “omics revolution.” He was previously director of communications and scientific education at the Broad Institute of MIT and Harvard. Prior to Broad, he was VP and Global Head of Communications for the Novartis Institutes of BioMedical Research. After receiving his Ph.D. in biological sciences from the University of Notre Dame, Fintan completed post-doctoral studies at the National Institutes of Health and Johns Hopkins School of Medicine.
After leaving active research in 1993, Fintan held several editorial positions for public and private scientific publishers, including “News” and “News & Views” editor for Nature Medicine, executive editor of Genomics, founding executive editor of Molecular Therapy and executive editor of Nucleic Acid Therapeutics, the journal of the Oligonucleotide Therapeutics Society. Fintan also holds a M.Div. degree from the St. Meinrad School of Theology and a Masters in medical ethics and religious studies from Indiana University, where he focused on ethical issues in genetics.